Revvity Inc. (NYSE:RVTY) Given Average Recommendation of “Moderate Buy” by Analysts

Revvity Inc. (NYSE:RVTY) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $114.75.

A number of brokerages have issued reports on RVTY. Bank of America reduced their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Robert W. Baird raised their price objective on Revvity from $122.00 to $123.00 and gave the company an “outperform” rating in a research report on Tuesday, October 28th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Revvity in a report on Monday. Guggenheim started coverage on Revvity in a research report on Wednesday, October 15th. They issued a “neutral” rating on the stock. Finally, Evercore ISI restated an “outperform” rating and set a $108.00 price target on shares of Revvity in a report on Monday, October 27th.

Hedge Funds Weigh In On Revvity

Several institutional investors have recently bought and sold shares of the business. CYBER HORNET ETFs LLC bought a new stake in shares of Revvity in the 2nd quarter worth about $32,000. MUFG Securities EMEA plc bought a new position in shares of Revvity in the 2nd quarter valued at about $34,000. UMB Bank n.a. grew its position in Revvity by 138.8% in the second quarter. UMB Bank n.a. now owns 406 shares of the company’s stock worth $39,000 after acquiring an additional 236 shares in the last quarter. CVA Family Office LLC increased its stake in Revvity by 79.0% during the second quarter. CVA Family Office LLC now owns 410 shares of the company’s stock worth $40,000 after acquiring an additional 181 shares during the last quarter. Finally, New Age Alpha Advisors LLC bought a new stake in Revvity during the first quarter worth approximately $44,000. Institutional investors own 86.65% of the company’s stock.

Revvity Trading Down 1.7%

RVTY stock opened at $100.81 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.75 and a quick ratio of 1.44. Revvity has a 1-year low of $81.36 and a 1-year high of $128.29. The business has a 50 day simple moving average of $95.01 and a two-hundred day simple moving average of $92.97. The company has a market capitalization of $11.43 billion, a price-to-earnings ratio of 50.66, a PEG ratio of 3.39 and a beta of 1.06.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, October 27th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The firm had revenue of $698.95 million for the quarter, compared to analysts’ expectations of $699.75 million. During the same quarter last year, the business posted $1.28 earnings per share. The company’s revenue for the quarter was up 2.2% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. Research analysts anticipate that Revvity will post 4.94 EPS for the current fiscal year.

Revvity declared that its board has authorized a share repurchase plan on Monday, October 27th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to purchase up to 8.7% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its stock is undervalued.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 6th. Stockholders of record on Friday, January 16th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, January 16th. Revvity’s dividend payout ratio is currently 14.07%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.